日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a minimum checklist to assess the quality of evidence produced using registry data for the evaluation of medical device safety and performance

制定一份最低限度的核查清单,用于评估利用注册数据生成的证据质量,以评价医疗器械的安全性和性能。

Hoogervorst, Lotje A; Nelissen, Rob G H H; Melvin, Tom; Piscoi, Paul; Wilkinson, Chris; Lubbeke, Anne; Gale, Chris P; Epstein, David; Overgaard, Soren; Walmsley, Phil; Szymanski, Piotr; Mohaddes, Maziar; O'Connor, Donal B; Geertsma, Robert E; Hoebert, Joëlle M; Fraser, Alan G; Marang-van de Mheen, Perla J

Magistral Compounding with 3D Printing: A Promising Way to Achieve Personalized Medicine

3D打印技术在药物配制中的应用:实现个性化医疗的一种很有前景的方法

Beer, Netta; Kaae, Susanne; Genina, Natalja; Sporrong, Sofia Kälvemark; Alves, Teresa Leonardo; Hoebert, Joëlle; De Bruin, Marie Louise; Hegger, Ingrid

Scenarios for 3D printing of personalized medicines - A case study

个性化药物3D打印的应用场景——案例研究

Beer, Netta; Hegger, Ingrid; Kaae, Susanne; De Bruin, Marie Louise; Genina, Natalja; Alves, Teresa Leonardo; Hoebert, Joelle; Kälvemark Sporrong, Sofia

Health policy and systems research in access to medicines: a prioritized agenda for low- and middle-income countries

药品获取方面的卫生政策和系统研究:中低收入国家的优先议程

Bigdeli, Maryam; Javadi, Dena; Hoebert, Joelle; Laing, Richard; Ranson, Kent

Future of the European Union regulatory network in the context of the uptake of new medicines

欧盟监管网络在新药推广应用背景下的未来

Hoebert, Joëlle M; Irs, Alar; Mantel-Teeuwisse, Aukje K; Leufkens, Hubert G M

National medicines policies - a review of the evolution and development processes

国家药品政策——演变与发展过程回顾

Hoebert, Joëlle M; van Dijk, Liset; Mantel-Teeuwisse, Aukje K; Leufkens, Hubert Gm; Laing, Richard O